RPRX — Royalty Pharma plc price, chart and key statistics

Price data

Price

$57.16

Change YTD

+47.93%

Next earnings

Nov 4, 2026

Market cap

32.9B2020-06 17.8B2026-10 32.9B+85.0% over the window

Enterprise value

44B

Shares outstanding

575M2020-06 365.9M2026-06 575M+57.1% over the window

52W low

$35.23

52W high

$64.38

From 52W high

-11.21%

From 52W low

+62.25%

52W range

75%

Beta

0.42

Volume

Rel volume

0.74×

30D volume

3M

30D $ vol

179.5M

Insider trading

Insider net 1W0 insider-days of buying (no priced lot) and 1 of selling ($239K) in the last 7 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$239K

Insider net 1M0 insider-days of buying (no priced lot) and 2 of selling ($6.1M) in the last 30 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$6.1M

Insider net 3M0 insider-days of buying (no priced lot) and 4 of selling ($12.7M) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$12.7M

Insider net 1Y0 insider-days of buying (no priced lot) and 27 of selling ($62.3M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$62.3M

Form 4 transactions by trade date, as filed; latest on file 2026-09-28.

Fundamentals

Sales (ttm)

2.5B2018-12 1.8B2026-06 2.5B+41.3% over the window

Sales/share

$4.412019-12 $4.962026-06 $4.41-11.1% over the window

EPS (ttm)

$1.462020-06 $6.622026-06 $1.46-77.9% over the window

FCF (ttm)

2.5B

FCF/share

$4.33

Book value/share

$17.022019-12 $16.782026-06 $17.02+1.4% over the window

Net margin

32.14%2018-12 76.8%2026-06 32.1%-58.1% over the window

ROE

8.33%2018-12 30.3%2026-06 8.3%-72.5% over the window

ROA

4.11%2019-12 18.9%2026-06 4.1%-78.2% over the window

Debt / equity

0.88×2019-12 0.972026-06 0.88-9.6% over the window

Current ratio

2.802019-12 2.502026-06 2.80+12.1% over the window

Growth (CAGR, ttm) · 10Y

Sales

+10.02%2025-06-30 → 2026-06-302.3B → 2.5B (+10.0% total)+2.41%2023-06-30 → 2026-06-302.4B → 2.5B (+7.4% total)+2.53%2021-06-30 → 2026-06-302.2B → 2.5B (+13.3% total)n/a

Net income

-20.40%2025-06-30 → 2026-06-301B → 815M (-20.4% total)+47.30%2023-06-30 → 2026-06-30254.9M → 815M (+219.7% total)-3.46%2021-06-30 → 2026-06-30971.6M → 815M (-16.1% total)n/a

Shares

-1.40%2025-06-30 → 2026-06-30583.2M → 575M (-1.4% total)-1.51%2023-06-30 → 2026-06-30601.8M → 575M (-4.5% total)-1.08%2021-06-30 → 2026-06-30607.2M → 575M (-5.3% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS

-17.13%2025-06-30 → 2026-06-30$1.76 → $1.46 (-17.1% total)+51.42%2023-06-30 → 2026-06-30$0.42 → $1.46 (+247.3% total)-5.70%2021-06-30 → 2026-06-30$1.96 → $1.46 (-25.4% total)n/a

Sales/share

+11.58%2025-06-30 → 2026-06-30$3.95 → $4.41 (+11.6% total)+3.97%2023-06-30 → 2026-06-30$3.92 → $4.41 (+12.4% total)+3.65%2021-06-30 → 2026-06-30$3.69 → $4.41 (+19.6% total)n/a

Book value/share

+4.54%2025-06-30 → 2026-06-30$16.28 → $17.02 (+4.5% total)+1.43%2023-06-30 → 2026-06-30$16.31 → $17.02 (+4.4% total)-0.14%2021-06-30 → 2026-06-30$17.14 → $17.02 (-0.7% total)n/a

Dividend/share

+5.82%2025-06-30 → 2026-06-30$0.86 → $0.91 (+5.8% total)+5.27%2023-06-30 → 2026-06-30$0.78 → $0.91 (+16.7% total)+22.38%2020-12-31 → 2026-06-30$0.30 → $0.91 (+203.3% total)n/a

Price

+56.69%2025-10-02 → 2026-10-02$36.49 → $57.16 (+56.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+28.70%2023-10-02 → 2026-10-02$26.81 → $57.16 (+113.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+9.54%2021-10-01 → 2026-10-02$36.23 → $57.16 (+57.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+59.73%2025-10-02 → 2026-10-02$35.80 → $57.16 (+59.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+32.02%2023-10-02 → 2026-10-02$24.83 → $57.16 (+130.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.13%2021-10-01 → 2026-10-02$32.23 → $57.16 (+77.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

39.1×2020-06 7.582026-10 40.33+431.8% over the window

P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.

21.7×2020-06 6.742026-10 21.74+222.5% over the window

Fwd P/E

10.2×

P/S (ttm)Market cap ÷ TTM revenue.

13.0×2020-06 9.192026-10 12.96+41.1% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

3.4×2020-06 1.892026-10 3.36+77.6% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

13.2×

EV/EBITDA (fy)

29.0×

EV/Sales (ttm)

17.3×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

7.58%

Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record, not what was actually paid over the past year. Shown only when the record holds a full payment cycle that agrees with the dividends the company reports paying; otherwise —.

1.64%

Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only where the forward yield is; otherwise —.

1.62%

Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year.

$0.94

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 575.0M ÷ 583.2M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

1.40%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (1.40%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($21B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

1.40%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($321.8M) ÷ today's market cap ($32.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.98%2020-06 0.0%2026-06 1.0%+466470.7% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $321.8M + TTM dividends $0) ÷ today's market cap ($32.9B). Same caveat as the cash buyback yield.

0.98%2020-06 0.0%2026-06 1.0%+466470.7% over the window

Vs own 10Y history

P/E

69th

P/OI

72nd

P/S

92nd

P/B

96th